Skip to main content
. 2018 Mar 30;9(24):16822–16831. doi: 10.18632/oncotarget.24706

Figure 2. Response and outcome based on PET2 evaluation.

Figure 2

Twenty-five patients had a PET2 evaluation. Nineteen were negative and 6 positive. Correlation to post-C2 (MRI2) and end-of-treatment (MRIe) MRI evaluation is provided. CRu: complete response unconfirmed; PR: partial response; SD: stable disease; PD: progressive disease; NE: not evaluable; CR: complete response; ORR: overall response rate; death*: death from lymphoma-unrelated cause.